<p>Hypomagnesemia is defined as ≤ 2.0 mg/dL (0.82mmol/L). Adjusted models includes age, dialysis vintage, sex, Diabetes mellitus, Kt/V, systolic blood pressure, albumin, potassium, C-reactive protein, sodium, blood urea nitrogen, parathyroid hormone, phosphorus, calcium, hemoglobin, furosemide, antiplatelet drug, vitamin K antagonist, angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, phosphate binder, vitamin D receptor antagonist, atrial fibrillation, gastric hemorrhage, cerebral infarction, and ischemic heart disease.</p><p>Logistic analysis between Proton Pump inhibitor use and hypomagnesemia.</p
In 2006, hypomagnesemia was first described as a complication of proton-pump inhibitors. To address ...
Magnesium (Mg(2+)) is the second most copious element inside human cells and the fourth most abundan...
We investigated the association among long- term proton-pump inhibitors (PPIs) use with serum magnes...
a<p>Adjusted for diabetes, congestive heart failure, malignancy, steroid use, and number of distinct...
BACKGROUND: Proton pump inhibitors (PPIs) are a class of medications indicated for the treatment of ...
<div><p></p><p><i>Background</i>: The reported risk of hypomagnesemia in patients with proton pump i...
<p>Reference category is the patients on no acid suppressive medications. β-coefficients ± s.e’s and...
Some evidence suggests that proton pump inhibitors (PPIs) are an under-appreciated risk factor for h...
Background: Although many case reports have described patients with proton pump inhibitor (PPI)-indu...
Severe hypomagnesemia is a serious clinical condition that can be complicated by life-threatening ar...
<div><p>Background</p><p>Although many case reports have described patients with proton pump inhibit...
Background: Proton pump inhibitors (PPI)-related hypomagnesemia is a potentially life-threatening ad...
Hypomagnesemia is defined by having a serum magnesium level of less than 1.7 mg/dL. The magnesium ba...
There is increasing evidence and case reports regarding proton pump inhibitor (PPI)-induced hypomagn...
BACKGROUND:Proton pump inhibitors (PPIs) are one of the most widely prescribed medications across th...
In 2006, hypomagnesemia was first described as a complication of proton-pump inhibitors. To address ...
Magnesium (Mg(2+)) is the second most copious element inside human cells and the fourth most abundan...
We investigated the association among long- term proton-pump inhibitors (PPIs) use with serum magnes...
a<p>Adjusted for diabetes, congestive heart failure, malignancy, steroid use, and number of distinct...
BACKGROUND: Proton pump inhibitors (PPIs) are a class of medications indicated for the treatment of ...
<div><p></p><p><i>Background</i>: The reported risk of hypomagnesemia in patients with proton pump i...
<p>Reference category is the patients on no acid suppressive medications. β-coefficients ± s.e’s and...
Some evidence suggests that proton pump inhibitors (PPIs) are an under-appreciated risk factor for h...
Background: Although many case reports have described patients with proton pump inhibitor (PPI)-indu...
Severe hypomagnesemia is a serious clinical condition that can be complicated by life-threatening ar...
<div><p>Background</p><p>Although many case reports have described patients with proton pump inhibit...
Background: Proton pump inhibitors (PPI)-related hypomagnesemia is a potentially life-threatening ad...
Hypomagnesemia is defined by having a serum magnesium level of less than 1.7 mg/dL. The magnesium ba...
There is increasing evidence and case reports regarding proton pump inhibitor (PPI)-induced hypomagn...
BACKGROUND:Proton pump inhibitors (PPIs) are one of the most widely prescribed medications across th...
In 2006, hypomagnesemia was first described as a complication of proton-pump inhibitors. To address ...
Magnesium (Mg(2+)) is the second most copious element inside human cells and the fourth most abundan...
We investigated the association among long- term proton-pump inhibitors (PPIs) use with serum magnes...